GoldenGolden
Advanced Search

Grand Angels

An angel group in Michigan that focuses on B2B technology, advanced manufacturing, agriculture technology, and life sciences companies that are currently generating revenues, or are pre-revenue with a clear path to exit

Grand Angels is an angel group in Michigan that focuses on B2B technology, advanced manufacturing, agriculture technology, and life sciences companies that are currently generating revenues, or are pre-revenue with a clear path to exit. Founded 2004 in Holland, Michigan, United States by Charles C. Stoddard and Craig T. Hall, this angel group invests in early stage ventures and seed. Its portfolio companies include Ocuphire Pharma, Ambiq Micro, HistoSonics, Micro-LAM Technologies, Tetra Discovery, Reconstruct, Blue Medora, Gemphire Therapeutics, and HistoSonics. As of February 2020, Grand Angels has made 18 investments. Their most recent investment was on July 22, 2019, when Ocuphire Pharma raised $5M. Grand Angels has raised two funds, their latest being Grand Angels fund III. This fund was announced on Feb 9, 2020 and raised a total of $11.8M.

Timeline

2004
Founded

Invested in

Patents

Products

Funding Rounds Participated In

People

Name
Role
LinkedIn

Damato Paul

Managing Director

Paul Damato

Managing Director

Timothy Parker

President

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Ambiq Micro

Blue Medora

Gemphire Therapeutics

HistoSonics

Micro-LAM Technologies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.